Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 1.00 |
| ▸ | LDHA | P00338 | 1/20 | 0.42 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | CPB1 | P15086 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | ABAT | P80404 | 1/20 | 0.31 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.31 |
| ▸ | GABRR2 | P28476 | 2/20 | 0.31 |
| ▸ | BLM | P54132 | 2/20 | 0.31 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | APEX1 | P27695 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Aconitic Acid SCHEMBL1275978 | 1.00 | TSHR (1.00) | TSHRKDM4ELDHASRRALOX15 | |
| Aconitic Acid SCHEMBL16935 | 1.00 | TSHR (1.00) | TSHRKDM4ELDHASRRALOX15 | |
| Aconitic Acid SCHEMBL219037 | 1.00 | TSHR (1.00) | TSHRKDM4ELDHASRRALOX15 | |
| Aconitic Acid SCHEMBL2022211 | 1.00 | TSHR (1.00) | TSHRKDM4ELDHASRRALOX15 | |
| Aconitic Acid SCHEMBL22334 | 1.00 | TSHR (1.00) | TSHRKDM4ELDHASRRALOX15 | |
| Aconitic Acid SCHEMBL29245497 | 0.97 | TSHR (0.95) | TSHRKDM4ELDHASRRALOX15 | |
| Aconitic Acid SCHEMBL9394649 | 0.97 | TSHR (0.95) | TSHRKDM4ELDHASRRALOX15 | |
| Aconitic Acid SCHEMBL27871922 | 0.97 | TSHR (0.95) | TSHRKDM4ELDHASRRALOX15 | |
| Aconitic Acid SCHEMBL30275008 | 0.97 | TSHR (0.95) | TSHRKDM4ELDHASRRALOX15 | |
| Aconitic Acid SCHEMBL27690462 | 0.97 | TSHR (0.95) | TSHRKDM4ELDHASRRALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4727448-A1 | OPTICAL CHEMICAL SENSOR SYSTEM WITH MICRONEEDLES | Cardiac Pacemakers, Inc. (US) | 2026-04-22 | — | — | EP | disclosed |
| US-20260034177-A1 | HUMAN FUNCTIONAL CORNEAL ENDOTHELIAL CELL AND APPLICATION THEREOF | KYOTO PREFECTURAL PUBLIC UNIV CORP (JP) | 2026-02-05 | — | — | US | disclosed |
| EP-4578465-A1 | INFECTION DETECTION SYSTEM | Paul Hartmann Aktiengesellschaft (DE) | 2025-07-02 | — | — | EP | disclosed |
| US-20240415417-A1 | OPTICAL CHEMICAL SENSOR SYSTEM WITH MICRONEEDLES | CARDIAC PACEMAKERS, INC. | 2024-12-19 | — | — | US | disclosed |
| WO-2024258781-A1 | OPTICAL CHEMICAL SENSOR SYSTEM WITH MICRONEEDLES | CARDIAC PACEMAKERS, INC. (US) | 2024-12-19 | — | — | WO | disclosed |
| US-20240415418-A1 | OPTICAL CHEMICAL SENSOR SYSTEM WITH MICRONEEDLES | CARDIAC PACEMAKERS, INC. | 2024-12-19 | — | — | US | disclosed |
| CN-118804934-A | Modified hyaluronic acid material and preparation method and application thereof | 爱美客技术发展股份有限公司 | 2024-10-18 | — | — | CN | disclosed |
| CN-118613596-A | Biomarkers for detecting and distinguishing invasive prostate cancer from inert forms and treatment of invasive prostate cancer | 约翰霍普金斯大学 | 2024-09-06 | — | — | CN | disclosed |
| CN-118453562-A | Nasal spray composition, nasal spray and application | 森宝(杭州)品牌运营有限公司 | 2024-08-09 | — | — | CN | disclosed |
| US-12053552-B2 | Functional wound dressing | PAUL HARTMANN AG (DE) | 2024-08-06 | — | — | US | disclosed |
| EP-3416658-B1 | HUMAN FUNCTIONAL CORNEAL ENDOTHELIAL CELL AND APPLICATION THEREOF | KYOTO PREFECTURAL PUBLIC UNIV CORP (JP) | 2023-03-22 | — | — | EP | disclosed |
| EP-3440999-B1 | SYSTEMS INCLUDING ELECTROLYTE SENSOR FUSION | CARDIAC PACEMAKERS INC (US) | 2023-03-08 | — | — | EP | disclosed |
| US-11571151-B2 | Implantable chemical sensor with staged activation | CARDIAC PACEMAKERS, INC. (US) | 2023-02-07 | — | — | US | disclosed |
| EP-3492014-B1 | MULTIMODAL ANALYTE SENSORS FOR MEDICAL DEVICES | CARDIAC PACEMAKERS INC (US) | 2022-10-19 | — | — | EP | disclosed |
| US-11439304-B2 | Systems and methods including electrolyte sensor fusion | CARDIAC PACEMAKERS, INC. (US) | 2022-09-13 | — | — | US | disclosed |
| EP-3495804-B1 | IMPLANTABLE MULTIMODAL OPTOELECTRONIC ANALYTE SENSOR | CARDIAC PACEMAKERS INC (US) | 2022-05-11 | — | — | EP | disclosed |
| CN-114209684-A | Application of itaconic acid in preparation of medicine for preventing and/or treating overweight or obesity or health-care product for preventing overweight or obesity | 北京谷海天目生物医学科技有限公司 | 2022-03-22 | — | — | CN | disclosed |
| EP-2477962-A1 | PRODRUGS OF GUANFACINE | Shire LLC (US) | 2012-07-25 | — | — | EP | disclosed |
| WO-2012046062-A1 | USE OF PRODRUGS TO AVOID GI MEDIATED ADVERSE EVENTS | SHIRE, LLC (US) | 2012-04-12 | — | — | WO | disclosed |
| WO-2011033296-A1 | PRODRUGS OF GUANFACINE | SHIRE LLC (US) | 2011-03-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260034177-A1 | HUMAN FUNCTIONAL CORNEAL ENDOTHELIAL CELL AND APPLICATION THEREOF | EPCAM, CD44, SLC17A5 | TSHR 2582/4885KDM4E 1778/4885LDHA 1138/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.